Frederick Abbott is Edward Ball Eminent Scholar Professor of International Law at Florida State University College of Law. He has served as expert consultant for numerous international and regional organizations, governments and nongovernmental organizations, mainly in the fields of intellectual property, public health, trade, competition and sustainable development. Professor Abbott is the author of many books and articles in the fields of international intellectual property rights law, public health, international economic law and international law. Recent books include International Intellectual Property in an Integrated World Economy, 4th ed. 2019 (with T. Cottier and F. Gurry)(information below), Emerging Markets and the World Patent Order, ed. with Carlos M. Correa and Peter Drahos (2013)(information below) and Global Pharmaceutical Policy (2009) (with G. Dukes). He served as a member of the Expert Advisory Group (EAG) to the High Level Panel on Access to Medicines appointed by the UN Secretary General in late 2015. He is Co-Chair of the Committee on Global Health Law of the International Law Association, having served as Rapporteur for the Committee on International Trade Law from the inception of its work in 1993 to its conclusion in 2014. He is a member of the Technical Advisory Group (TAG) to the WHO C-TAP program (having also served as consultant to the World Health Organization on a variety of projects), and is consultant to the United Nations Development Program and other multilateral institutions. Professor Abbott is on the editorial board of the Journal of International Economic Law (Oxford), the WIPO-WTO Colloquium Series and the Journal of Intellectual Property Rights (NISCAIR/India). He regularly serves as panelist for the WIPO Arbitration and Mediation Center.  He is on the panel of arbitrators under the dispute settlement mechanism of the CARIFORUM-EU Economic Partnership Agreement. He has served as counsel to governments in WTO dispute settlement proceedings, and in national court proceedings. Prior to entering academia, Professor Abbott was partner in a major US law firm and specialized in international business regulation and technology-related transactions. He was based in San Francisco (1977-1983 and Silicon Valley (1984-1989). Professor Abbott is Executive Director of the Global Medicines Council, a non-profit organization addressing medicines innovation and access. He is a graduate of the Yale Law School and the University of California, Berkeley.

Recent activities 

October 29, 2021: Panel Chair: Global Governance and World Health Organization Reform in the Wake of COVID-19, International Law Weekend, American Branch of the International Law Association (ABILA)

October 19, 2021: Presentation, The COVID-19 Technology Transfer Environment and the Potential Uses of WIPO’s New ADR OptionsOnline Workshop on New WIPO ADR Options for Life Sciences, WIPO’s COVID-19 Related Services and Support, (Geneva) Online

September 30, 2021: Keynote presentation, Trends in the Development and Use of Competition Law to Promote Access to the Benefits of Health Technologies, A Dialogue: Trends and Strategies in the Use of Competition Law to Promote Innovation of and Affordable Access to Health Technologies, UNDP in cooperation with the Government of Namibia and the Namibia Competition Commission, Online

September 24, 2021: The Work Program of the Global Health Committee in an Era of Unprecedented Challenges, The COVID-19 Pandemic and International Law, German Association of International Law, Working Group: International Health Law & Max Planck Institute for Comparative Public Law and International Law 

September 16, 2021: Keynote Address, Excessive pricing doctrine in the pharmaceutical sector: past, present and future, EU Competition Law and Pharmaceuticals Workshop, hosted by the Netherlands Authority for Consumers and Markets (ACM) 

July 20, 2021: Speaker at International Seminar on “Harnessing Public Research for Innovation in the Time of COVID-19 and Beyond – The Role of Knowledge Transfer Policies”, organized by the World Intellectual Property Organization (WIPO), in cooperation with AUTM, ICC and LESI, Geneva (online)

July 2021: Appointed to the Technical Advisory Group (TAG) on the World Health Organization COVID-19 Technology Access Pool (2-year term)

June 23, 2021: Panelist presentation at first WHO World Local Production Forum, Session 4, Expanding Access to Affordable Capital, Geneva (online)

May 12, 2021: Localization of Pharmaceutical Production and the Dissemination of Health Technologies, World Trade Organization, 2021 Trade and Public Health Virtual Course Webinar: Dissemination of Health Technologies, YouTube link:

April 20, 2021: Using Competition Law to Promote Affordable Access to Health Technologies in Low-and Middle-Income CountriesFair Pricing in times of public health emergency and to accelerate achievements of Sustainable Development Goals health targets, World Health Organization 2021 Fair Pricing Forum, organized with the support of Argentina

March 18, 2021: F. Abbott, R. Abbott, J. Fortunak, P. Gehl Sampath & D. Walwyn, Opportunities, Constraints and Critical Supports for Achieving Sustainable Local Pharmaceutical Manufacturing in Africa: With a Focus on the Role of Finance, Final Report, March 18, 2021 (Nova Worldwide), also available at (with Executive Summary and Addenda); DOI: 10.33009/osf-php_report; DOI link:

February 2021: Child-Proofing Global Public Health in Anticipation of Emergencyproject on Global Governance: The World Health Organization (WHO) and the Need for Post-COVID-19 Reform collection in Washington University Global Studies Law Review (forthcoming 2021)

September 2020: Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic (co-author with Jerome H. Reichman), Journal of International Economic Law (Oxford)(Volume 23, Issue 3, pp. 535-561, Sept. 2020)

August 2020: The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 PandemicResearch Paper 116, South Centre, Geneva (August 2020)

June 12, 2020: World Trade Organization Faces Leadership Battle In Shadow Of Crisis Over Organization’s Future, Health Policy Watch; Confronting COVID-19 In A World Without WHO – Seriously?, Health Policy Watch, April 14, 2020 

See COVID-19 related materials at ILA Global Health tab; International Law Association adopts Resolution No. 2/2020 - Statement regarding the COVID-19 pandemic at the 79th Kyoto Conference, Nov.-Dec. 2020 

A detailed curriculum vitae is available here

For more information contact:


Website design by BlueAntWorks

Current Issues


International Experiences and Access to Medicines: Synthesizing Trends and Reflecting on Paths Forward, Presentation at Fair and Equitable Pricing in Health: Competition Law and Access to Medicines, South Centre/IDEC Webinar, December 3-4, 2020 

Do Trade Rules on Intellectual Property Represent an Obstacle to Global Access to a Coronavirus Vaccine?, Presentation at Queen’s Institute on Trade Policy 2020, Trade Rules for the Pandemic and Its Aftermath, November 25, 2020, Canada (online)

Presentation at WHO Workshop - Understanding patents and other intellectual property relevant to local production, October 28, 2020

Webinar with Frederick Abbott and Gian Luca Burci, et al, COVID-19 and International Law: A Snapshot, a CLE seminar hosted on April 28, 2020, by the Bar Association of Metropolitan St. Louis, Whitney R. Harris World Law Institute at Washington University in St. Louis School of Law, and the International Law Association (American Branch)

Article: Under the Radar: Reflections on ‘Forced’ Technology Transfer and the Erosion of Developmental Sovereignty in GRUR International (Oxford), Issue 3 (planned), forthcoming 2020

Presentation on Pharmaceuticals, Market Exclusivities and Abuse of Dominance: The Evolution of Excessive Pricing DoctrineHow much is too much? at Excessive Pharmaceutical Prices in European Competition Law & Regulation, CeBIL, Copenhagen University, November 6, 2019

Presentation on Law and its limitations in global public health: Non-voluntary patent licensing post-Doha at Innovation, Justice, and Globalization – A Celebration of J.H. Reichman, 26-27 September 2019 • Harvard Law School, Harvard University

Presentation on TRIPS, Strategic Competition and Global Welfare: IP at the Intersection of Law and Power at Conference on A Changing International Economic Order and the Response from International Law, at University of International Business and Economics (UIBE), Beijing, China, September 26, 2019

Presentation on Health Technologies, Market Exclusivities and Abuse of Dominance: Methodology and Structure for Competition Law Enforcement, at IP Researchers Europe Conference. organized by the World Intellectual Property Organization (WIPO), the World Trade Organization (WTO) and the School of Law, University of Geneva (UNIGE), Geneva, June 28 and 29, 2019

Presentation on Technology Transfer and Development, Distinguished Honorary Panel, CEIPI/WIPO/INPI Advanced Training Course, Strasbourg, France, June 21, 2019

Working Paper, TRIPS, Strategic Competition and Global Welfare: IP at the Intersection of Law and Power, Presented at Symposium on the TRIPS Agreement at 25, Texas A&M Law School, Fort Worth, Texas, March 29, 2019

In Memoriam: Dilip Shah (1941-2019)Intellectual Property Watch, February 23, 2019

Using competition law to address high medicines prices: Webinar, with accompanying PowerPoint, Global Health Centre – Graduate Institute|Geneva, January 15, 2019

Presentations on IP, Trade and Development and IP and Health at Summit on Global Trade, Technology Innovation, Intellectual Property and Development, WTO and China Academy of International Trade and Economic Cooperation, with WIPO, 15-16 October 2018, Xiamen, Fujian, China

Developments and Trends in Competition Law and Practice, 5th Global Congress on Intellectual Property and the Public Interest, Washington, DC, September 28, 2018

Report on Activities at International Law Association Sydney Biennial - August 2018

The UK Competition Appeal Tribunal’s Misguided Reprieve for Pfizer’s Excessive Pricing Abuse, in IIC - International Review of Intellectual Property and Competition Law, Volume 49, Number 7 (2018)

Excessive Pricing and Sham Patent Litigation: The Pfizer and AbbVie Decisions, Intellectual Property Watch, July 3, 2018

Report of the Global Health Law Committee of the International Law Association prepared for the 2018 Sydney Biennial Conference, August 19-24, 2018


US China Relations Papers by Frederick M. Abbott

US Section 301, China, and technology transfer: Law and its limitations revisited (again), International Center for Trade and Sustainable Development (ICTSD), Opinion, May 23, 2018

Reflection Paper on China in the World Trading System: Defining the Principles of Engagement in CHINA IN THE WORLD TRADING SYSTEM: DEFINING THE PRINCIPLES OF ENGAGEMENT, pp. 1-43, F.M. Abbott, ed., Kluwer Law International 1998

Technology and State Enterprise in the WTO in STATE TRADING IN THE TWENTY-FIRST CENTURY 121, T. Cottier and P. Mavroidis, eds., U. Mich. Press 1998

China in the WTO 2006: 'Law and its Limitations' in the Context of TRIPS in WTO LAW AND DEVELOPING COUNTRIES, pp. 59-81, G. Bermann, P. Mavroidis, eds., Cambridge Univ. Press, 2007

China Policies to Promote Local Production of Pharmaceutical Products and Protect Public Health, Published by: Geneva: World Health Organization; 2017

About the Book

Link to Amazon

Link to Kluwer/Aspen

International Intellectual Property in an Integrated World Economy, Fourth Edition

International Intellectual Property in an Integrated World Economy features a comprehensive introduction to the global system regulating the field of intellectual property rights, including how the treatment of IP may affect a broad range of social and political interests.  

About the book

Link to Amazon

Link to Elgar

Link to Google Play

From the Publisher:

Emerging Markets and the World Patent Order

Edited by Frederick M. Abbott, Edward Ball Eminent Scholar Professor of International Law, Florida State University College of Law, US, Carlos M. Correa, Professor and Director, Centre for Interdisciplinary Studies on Industrial Property and Economics (CEIDIE), Law Faculty, University of Buenos Aires, Argentina and Peter Drahos, Professor, Regulatory Institutions Network, The Australian National University and Chair in Intellectual Property, Queen Mary, University of London, UK

Description The patent has emerged as a dominant force in 21st century economic policy. This book examines the impact of the BRICS and other emerging economies on the global patent framework and charts the phenomenal rise in the number of patents in some of these countries.

Contributors include: F.M. Abbott, D. Borges Barbosa, C.M. Correa, P. Drahos, M. El Said, C. Fink, P. Gehl Sampath, K. Karachalios, R. Kher, J. Kuanpoth, A. Kudlinski, T. Payosova, P. Roffe, S.K. Sell, Y. Tamura, G. Van Overwalle, Y.A. Vawda, H. Zhang, W. Zhuang

New Fourth Edition 2019

Emerging Markets

Global Pharmaceutical Policy

In the News


Comment on US Supreme Court decision adopting and affirming international exhaustion of patents published in IIC
, Nov. 2017

Presentations at DTI South Africa - Workshop on Draft Intellectual Property Policy, Policy Coherence, IP and Competition, Compulsory Licensing and Government Use, October 25-27, 2017

Presentation (PPT and Audio),
A Never-ending Tale: IP governance, the (captured) regulatory state and the world of second bestsConference in Honour of Pedro Roffe, Geneva, June 15, 2017
IP-Watch, Inside Views: US Supreme Court Adopts International Exhaustion of Patents (Part II): Addressing the New Competitive Landscape, June 8, 2017
IP-Watch,Inside Views: US Supreme Court Adopts International Exhaustion for Patents: Paving the way for parallel imports to exert downward pressure on domestic pharmaceutical (and other) prices, May 31, 2017
Presentation (PPT and Audio), Competition Doctrines for the Medicines Sector: Innovation and Affordability, 7th ASEAN Competition Conference 2017 - ASEAN@50  – Managing Change in a Competitive ASEAN, March 8, 2017. Kuala Lumpur, Malaysia
Presentation (PPT) on Non-Voluntary Patent Licensing in International Law at Workshop on the History, Experiences, and Prospects of Compulsory Licensing of Medical Patents in the United States, KEI – February 24, 2017, Washington, DC
Presentation (audio) at WTO@20 Conference, New Delhi - The WTO and Intellectual Property in the Midst of Tectonic Shift, 17 February 2017
Amicus Brief to Supreme Court filed January 20, 2017 in Impression Products v. Lexmark International (International Exhaustion of Patents)
Lecture on Trade and Economic Impact of Trump Election, Nov. 9, 2016
Presentations at South Africa Department of Trade and Industry, UNDP, UNCTAD Public Consultation on Intellectual Property Policy, Pretoria, Sept. 28-30, 2016
Meeting of ILA Global Health Law Committee, Johannesburg, Aug. 9, 2016
No dispute on public health, The Hindu BusinessLine, July 22, 2016 (Uruguay ISDS tobacco case)
Initiation of Pharmaceutical Sector Inquiry in Indonesia,, May 25, 2016
Presentation at Official BRICS Side Event, 69th World Health Assembly, Geneva, May 23, 2016, TRIPS plus provisions in plurilateral/regional trade agreements and their impact on access to medicines at the national and global level 
Submission to Senate Finance Committee on March 3, 2016 in response to request feedback regarding the report on “The Price of Sovaldi and its impact on the U.S. Health Care System”
Global Health Law Committee submissions to UN High Level Panel on Access to Medicines process to be presented in London on March 9, 2016
Peter Gosselin, Obama Pushes Trade Partners to Add Drug Rules He Opposes in U.S., Washington Post/Bloomberg News, July 10, 2015
Soumonty Kanungo, Biased? India has a balanced pharma patent regime, DNA India, June 15, 2015
Anju Ghangurde, Prof Abbott on Lilly's 'borderline absurd' ISDS plaint and the TPP, SCRIP Intelligence, June 10, 2015

Recent Postings

Excessive Pharmaceutical Prices and Competition Law: Doctrinal Development to Protect Public Health, forthcoming in UC Irvine Law Review, Volume 6, Issue 3, Spring 2017

Rethinking Patents: From ‘Intellectual Property’ to ‘Private Taxation Scheme’in KRITIKA: ESSAYS ON INTELLECTUAL PROPERTY, vol. 1, pgs. 1-16 (eds. P. Drahos, G. Ghidini, H. Ullrich), Edward Elgar 2015

Trade in medinesin Trade and Health: Towards building a National Strategy 117-40 (eds. R. Smith et al.), World Health Organization (2015)

Third Contribution to Roundtable on Climate mitigation and intellectual property in tension, Let a thousand technologies bloom (Bulletin of the Atomic Scientists, Mar. 13, 2015)

Second Contribution to Roundtable on Climate mitigation and intellectual property in tension, Aggregating capital, addressing climate change (Bulletin of the Atomic Scientists, Mar. 13, 2015)

Summary Report of Global Health Security Meeting, ILA Global Health Law Committee - Graduate Institute|Geneva Global Health Programme, Feb. 19, 2015

Contribution to Roundtable on Climate mitigation and intellectual property in tension, A problem, but not without solutions (Bulletin of the Atomic Scientists, Feb. 19, 2015)

Recent Presentation: Groundhog Day: Health-related provisions in FTAs and TRIPS (ICTSD Dialogue, Oct. 30, 2014)

Recent Presentation: Transfer of Technology and a Global Clean Energy Grid (World Trade Forum, Sept. 27, 2014)

Articles and Studies: The LDC Medicines Extension Question: Contemplating next steps (Bridges Africa, Sept. 2014)






Author Interview

IP-Watch Interview

May 21, 2014 William New interviews Frederick Abbott

Discussing Emerging Markets and the World Patent Order

Link to text

Subscribe to RSS